.FDA declines experimental MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Approve MDMA Therapy, Seeking More Research Study The Nyc TimesFDA Turns Down Ecstasy-Based Medication The Commercial JournalFDA refuses to authorize novel MDMA therapy to address post-traumatic stress disorder, along with ask for even more litigation information CNNFDA rejects initially experimental to alleviate post-traumatic stress disorder, calling for more research The Washington Message.